Sign inJoin waitlistJoin the waitlist

Braden Kuo

Chief, Division of Digestive & Liver Diseases · NewYork-Presbyterian Hospital and the Vagelos College of Physicians and Surgeons

Credentials: · · · · ·

History

Division of Digestive & Liver Diseases · NewYork-Presbyterian Hospital and the Vagelos College of Physicians and Surgeons
Present
Vagelos College of Physicians and Surgeons
Present

Massachusetts General Hospital - Harvard University
Parkland Memorial Hospital
Jefferson Medical College
1994

Research

Comparison of gastric emptying of a nondigestible capsule to a radio-labelled meal in healthy and gastroparetic subjects
Alimentary Pharmacology & Therapeutics · 2008 · First of 12 authors · Corresponding · 244 citations
Investigation of colonic and whole-gut transit with wireless motility capsule and radiopaque markers in constipation
Clinical Gastroenterology and Hepatology · 2009 · 241 citations
ACG Clinical Guideline: Gastroparesis
The American Journal of Gastroenterology · 2022 · 233 citations

Kyle Staller
62 papers · 8 as a resident
Henry Parkman
52 papers
RM
Richard Mccallum
43 papers
KK
Kenneth Koch
31 papers
Thomas Abell
31 papers
WH
William Hasler
28 papers
PP
Pankaj Pasricha
26 papers
Gianrico Farrugia
25 papers
Madhusudan Grover
24 papers
JT
James Tonascia
23 papers · 17 as a resident
FH
Frank Hamilton
21 papers
Robert Shulman
18 papers

Grants

A Consortium for Gut-Brain Communication in Parkinson's Disease- Supplement
National Institute of Diabetes and Digestive and Kidney Diseases · U01
Contact PI · $2.1M · Columbia University Health Sciences
2024–2029
New England Gastropareis Consortium: Neurobiology of Gastroparesis
National Institute of Diabetes and Digestive and Kidney Diseases · U01
Contact PI · $4.8M · Massachusetts General Hospital
2016–2027
Thoracic Neuromodulation for Diabetic Gastroparesis
National Institute of Diabetes and Digestive and Kidney Diseases · R01
PI · $812.5K · Medical University of South Carolina
2022–2027
Translumbosacral Neuromodulation Therapy for Fecal Incontinence: Randomized Trial
National Institute of Diabetes and Digestive and Kidney Diseases · R01
PI · $2.6M · Augusta University
2019–2025

Clinical trials

Comparison of the Atmo Motility Gas Capsule System to the Reference Standard
Principal investigator · Unknown
Atmo Biosciences Pty Ltd
2023–2024
Evaluation of the Gastrointestinal Manifestation of Fabry's Disease
Principal investigator · Completed
Massachusetts General Hospital
2016–2022
Clinical Management With SPM System and Validation of the SPM 5 Hour Cutoff in Patients With Symptoms of Gastroparesis
Principal investigator · Terminated
Medtronic - MITG
2014–2017
A Pilot Study on the Efficacy and Safety of Olanzapine in Gastroparesis
Principal investigator · Terminated
University of Michigan
2013–2019